Only a handful of places left for our September 2026 cohort. Applications close soonApply now →

MSTA
Your future
starts here.

Comedone Extraction

Also known as: extractions, clinical extractions, comedone extraction

Comedone extraction is the mechanical expression of the impacted keratin-sebum plug from a blocked pilosebaceous follicle, using a loop extractor and, for closed comedones, a fine needle or lancet to pierce the surface first. It empties existing lesions; it does not alter follicular hyperkeratinisation.

Evidence status

Limited

Comedone extraction has a plausible immediate effect and one 2024 split-face RCT recorded a 46.4% reduction, although CO2 laser achieved 64.5%. NICE, AAD and the 2024 Cochrane physical-therapy overview do not recommend or meaningfully evaluate extraction; the only national guideline located that recommends it is a 2008 Indian guideline at its lowest evidence grade. Human studies are few, old or uncontrolled, and destructive treatment without diagnosis remains a material safety boundary.

What comedone extraction is, and the types available#

Comedone extraction is the controlled mechanical expression of keratin and sebum from a blocked pilosebaceous follicle. Published Indian acne-surgery guidance notes that a closed comedone has an intact surface and may require deliberate skin opening before expression. That changes the scope, asepsis, sharps and insurance questions; the exact instrument and technique belong to verified training and manufacturer policy.[11]

Open comedones have a visible dilated follicular opening. Closed comedones sit beneath an intact surface and are easier to mistake for milia or another papule. Inflamed papules, pustules, nodules and cysts are not simply “deeper comedones” and do not inherit the same procedure.

Extraction removes the contents already present. It does not alter follicular hyperkeratinisation, sebum production or the inflammatory biology of acne, and the trial literature describes the effect as temporary and potentially irritating.[5, 11]

Use of comedone extraction in aesthetic practice#

Comedone extraction is not named in the UK-wide JCCP competence framework or in the England, Scotland and Wales instruments reviewed. Those lists are either non-exhaustive or closed by subject matter, so absence means unaddressed rather than prohibited. The sources reviewed do not establish the position in Northern Ireland, which requires a separate local check.[13, 14, 16, 17, 18, 19]

England's scheme remains a proposal and is not in force. Local-authority licensing, premises requirements, infection-control duties and insurance terms may still apply. A lancet or extractor marketed as a medical device falls under the UK Medical Devices Regulations according to its manufacturer's intended purpose; many beauty tools are marketed outside that regime.

No extraction-specific national decontamination or single-use standard is cited in the available UK guidance. The most explicit published technique guidance merely says to cleanse with spirit and gives no instrument-sterilisation standard. That absence is not permission to improvise: the manufacturer's instructions, infection-control policy, local licensing conditions and insurer requirements govern the instruments used.[11, 15]

Contraindications and cautions#

Routine aesthetic extraction is unsuitable for inflamed papules, pustules, nodules or cysts; active bacterial or viral infection; open or excoriated skin; an impaired barrier; an undiagnosed papule or pigmented lesion; and any lesion around which diagnosis is uncertain. Acne with nodules, cysts, scarring or substantial psychosocial effect belongs to medical assessment.

Pigment risk matters. In a sequential study of 324 acne patients across seven Asian countries, 188 (58.2%) had post-inflammatory hyperpigmentation; it lasted at least one year in more than half and five years or longer in 22.3%. Excoriation was a commonly reported modifiable factor. The paper discussed Fitzpatrick III–VI skin but did not report measured phototypes, so 58.2% is not a phototype-stratified extraction risk.[9]

NICE advises that persistent picking or scratching can increase acne-scarring risk, based on committee experience because direct evidence was limited. A controlled professional procedure differs from prolonged self-excoriation, but no study establishes that professional extraction escapes the same inflammation-to-scar pathway.[1, 2][1, 2]i

The central face also requires caution. The so-called facial danger triangle contains venous communications with the cavernous sinus. Cadaveric work found valves in 75% of superior ophthalmic vein specimens and 17 bicuspid valves in facial-vein and angular tributaries, so the risk is not explained by a complete absence of valves; communications and flow direction matter. Forced manipulation or lancing of an inflamed lesion around the nose, upper lip or medial cheek belongs with a clinician.[10][10]i

Clinical uses and the evidence behind them#

Predominantly comedonal acne

One national guideline supports extraction: the Indian Association of Dermatologists, Venereologists and Leprologists' 2008 acne-surgery standard lists it for Grade 1 predominantly comedonal acne, aiming at faster lesion resolution. It assigns Level D, its lowest evidence grade, and notes that some experts believe scarring may increase when precautions are inadequate.[11]

No UK national guideline supports it. NICE NG198's physical-treatment section contains one recommendation, for photodynamic therapy in selected moderate-to-severe adult acne, and does not mention extraction. NICE's committee also recorded that physical acne treatments were not current NHS practice and that evidence in mild-to-moderate acne was very limited. The American Academy of Dermatology's 2024 guideline issued 18 recommendations and five good-practice statements without naming extraction among the recommendations or four statements identified in its abstract.[1][2][3]

A 2024 Cochrane overview screened 733 records and included six low-risk-of-bias reviews spanning 275 trials and 40,910 participants. Although it set out to cover physical therapies, it did not evaluate comedone extraction.[4]

Direct comparative evidence

The only randomised trial using manual extraction as a comparator was a 2024 evaluator-blind split-face study in dense comedones. Four extraction sessions at two-week intervals reduced mean comedone counts by 46.4%, and 37.5% of extraction-treated sides exceeded 50% clearance. Ultra-pulse CO₂ laser on the contralateral sides achieved 64.5% mean reduction and 79.2% over 50% clearance (P<0.001 for reduction rates); extraction was more painful. The schedule is a study condition, not a generic treatment recommendation. The absence of an untreated side means the trial shows extraction underperforming an active comparator, not outperforming no treatment.[5][5]

Funding and conflict statements are unavailable in the accessible record, which matters because the finding favours a commercial laser platform over the manual comparator. A manufacturer interest can neither be confirmed nor excluded.[5]

Historical support comes from a 1964 within-patient comparison: comedones were extracted unilaterally on 20 foreheads and 12 cheeks, with the abstract not establishing whether these were the same patients. It reported prevention of inflamed lesions in most foreheads and in very superficial acne elsewhere, but little value in cystic acne. No randomisation, blinding, lesion counts or statistical testing were reported.[7]

The evidence does not show that professional extraction reduces acne scarring, prevents inflammatory progression or improves long-term acne outcomes. The broader dermatology literature has long acknowledged that trials of in-office adjunctive acne procedures are few and small.[12][no source found]

Selecting comedone extraction#

Selection begins with lesion identity and the treatment goal. A discrete non-inflamed comedone that can be clearly distinguished from milia, sebaceous hyperplasia or another papule is different from widespread comedonal acne needing prevention. Extraction can empty the first; it cannot provide the long-term control expected from guideline-backed topical therapy.

Published technique guidance stresses that undue force increases inflammation and may scar. It also treats deliberate opening of an intact closed comedone as part of the procedure. That Level-D guidance does not create a universal protocol. Instrument choice, permitted skin penetration, asepsis and technique follow verified training, the insurer, local rules and the exact product instructions.[11]

No comparative study establishes an optimal loop, multi-hole extractor, forceps design, pressure, pre-softening method or keratolytic preparation. The common rationale that heat or a keratolytic reduces extraction force has not been tested comparatively.

Adverse effects and their management#

Expected local response

Post-extraction erythema is recognised sufficiently clearly to have served as the primary target in a 35-person randomised split-face laser study. Brief redness and tenderness are therefore foreseeable tissue responses, not efficacy endpoints.[6]

Inflammation, pigment and scarring

Excess pressure, repeated attempts and tissue tearing can increase inflammation and scarring risk.[11] In clients prone to post-inflammatory hyperpigmentation, even a small visible lesion may be replaced by pigment lasting much longer than the comedone. The magnitude of that trade-off has never been measured in an extraction trial.[9, 5]i

Infection and misdiagnosis

Increasing pain, heat, spreading erythema, purulent discharge or systemic symptoms require medical assessment. Failure of a presumed comedone to express is a reason to stop and reconsider the diagnosis, not to escalate force.

No UK complication registry or incidence estimate is available for extraction performed in beauty or aesthetic settings. The absence of a number means risk cannot be quantified, not that complications do not occur.[no source found]

Referral and scope boundaries#

Medical assessment is indicated for inflammatory or nodulocystic acne, established or progressive scarring, recurrent widespread comedones despite appropriate skincare, suspected infection, and acne associated with significant distress. NICE-backed acne care belongs to the medical pathway even when cosmetic support continues.

Any uncertain, firm, rapidly changing, ulcerated, bleeding or pigmented lesion is assessed diagnostically before manipulation. Deep or inflamed lesions in the central facial triangle should not be lanced or forcibly expressed in an aesthetic facial.[10]

Persistent pigment after manipulation links to post-inflammatory hyperpigmentation; repeated self-excoriation may need behavioural or medical support. The underlying acne belongs to the acne-vulgaris entry, and long-term comedone prevention belongs to evidence-based topical treatment rather than repeated emptying.

Mechanism of action#

Mechanical manipulation expresses the impacted keratin-sebum plug through the follicular opening. Published guidance recognises that intact skin over a closed comedone changes the procedure and may involve deliberate opening.[11]

The mechanism is immediate and local. It does not normalise keratinocyte shedding or prevent the next plug, which explains why the 2024 trialists characterised its effect as temporary.[5] Any benefit from pre-softening or keratolytics remains mechanistic reasoning rather than a measured reduction in tissue trauma.

Commonly misstated claims#

“Extraction is the professional standard for comedonal acne.”

NICE, the AAD and the Cochrane overview do not recommend or evaluate it as a standard acne treatment.[1, 3, 4] The 2008 Indian acne-surgery standard does recommend it for Grade 1 comedonal acne, at Level D with a scarring caution.[11]

Supported statement: extraction is a taught adjunct with one low-grade non-UK guideline recommendation, not a UK guideline-backed acne treatment.

“The facial danger triangle is dangerous because its veins have no valves.”

Valves were found in most superior ophthalmic vein specimens and in facial and angular tributaries. The clinically important anatomy is the communication with the cavernous sinus and the direction of flow.[10]

Supported statement: central-facial infection can spread through venous communications; the traditional “no valves” explanation is inaccurate.

“A study of 4,566 people proved extraction cures acne.”

That figure comes from an uncontrolled single-clinic series using a non-standard tweezers technique, with no comparator, randomisation, validated cure definition or adverse-event denominator.[8]

Supported statement: the case series reports outcomes from its own non-standard technique and cannot establish that comedone extraction cures acne.

“Professional extraction is proven not to scar.”

No randomised scarring-outcome study is available. NICE's picking advice and the Indian guideline's caution both point to trauma and inflammation as relevant, but neither quantifies risk from professional extraction.[1, 2, 11]

Supported statement: controlled low-force technique is intended to limit trauma, while the comparative scarring risk remains unmeasured.

Areas of remaining uncertainty#

  • Whether sterile low-force professional extraction has a different scarring and PIH risk from self-excoriation; without a comparative study, the distinction remains plausible rather than proven.
  • Whether extraction offers any benefit over leaving a comedone untreated; without an untreated control, effect size cannot be estimated.
  • How immediate clearance balances against later inflammation and pigment; without lesion-level follow-up, consent cannot attach a reliable probability.
  • Whether pre-softening or keratolytics reduce force and adverse effects; without comparative evidence, product instructions rather than folklore govern.
  • Whether existing results generalise to Fitzpatrick V–VI; the trials do not report a phototype distribution, so pigment-risk estimates cannot be stratified.

Frequently asked questions#

Is extraction recommended by NICE for acne?

No. NICE NG198 does not mention comedone extraction and recommends medical and topical pathways for acne.[1]

Does extraction prevent future comedones?

No evidence establishes that. It empties an existing lesion without changing the follicular process that formed it.[5, 11]

Is post-extraction redness normal?

Brief erythema is recognised after the procedure. Persistent, spreading, painful or hot redness requires assessment rather than being treated as routine.[6]

Is it safer than a client picking at home?

A controlled sterile procedure is different in practice, but no study has quantified whether it carries less scarring or PIH risk than self-manipulation.[1, 2]

What technique or instrument should be used?

The instructions for the exact instrument, the practitioner's verified training, infection-control policy, local requirements and insurance govern. The evidence does not establish a generic extraction protocol.

References#

Each source is graded by evidence tier. Tier 4 material (manufacturer documents, expert consensus, practitioner experience) is useful for protocol and context, and is never presented as equivalent to independent clinical evidence.

  1. National Institute for Health and Care Excellence. Acne vulgaris: management. NICE guideline NG198. Published 25 June 2021, last updated 30 April 2026. Recommendations.Tier 1Supports: Fetched and read in full. Section 1.5 'Physical treatments' contains exactly ONE recommendation, 1.5.29: 'Consider photodynamic therapy for people aged 18 and over with moderate to severe acne if other treatments are ineffective, not tolerated or contraindicated.' The words 'comedone extraction', 'comedo extraction', 'acne surgery' and 'extraction' do not appear anywhere in the recommendations. Recommendation 1.2.4 (Skin care advice): 'Advise people that persistent picking or scratching of acne lesions can increase the risk of scarring.' A further recommendation states: 'Take into account that the risk of scarring increases with the severity and duration of acne.' Scope limit: England/Wales NHS guideline for acne vulgaris management; it does not address aesthetic-clinic or beauty-therapy practice, and its silence on extraction is an absence of recommendation, not an explicit prohibition.
  2. National Institute for Health and Care Excellence. Acne vulgaris: management. NICE guideline NG198. Rationale and impact.Tier 1Supports: Fetched and read in full. On physical treatments: 'Physical treatments for the management of acne are not part of current practice in the NHS.' The photodynamic therapy recommendation rests on 'modest evidence'; 'The evidence for physical treatments for mild to moderate acne was very limited.' The committee 'noted that the evidence for some treatment options such as physical treatments, chemical peels and hormone-modifying treatments was limited' and made a research recommendation on the effectiveness of physical treatments. On picking/scratching: 'The committee discussed how people often pick or scratch their acne lesions. In the committee's experience this can lead to scarring, so they recommended that people are advised to avoid these behaviours. Given that the evidence on risk factors for scarring was limited the committee decided that further information was needed.' Scope limit: the picking/scratching advice is explicitly committee experience plus limited evidence, not trial data, and concerns client self-manipulation.
  3. Reynolds RV, Yeung H, Cheng CE, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024 May;90(5):1006.e1-1006.e30. PMID 38300170. Erratum: J Am Acad Dermatol. 2026 Jul;95(1):347.Tier 1Supports: Abstract fetched verbatim from PubMed (E-utilities). Citation independently verified: 16 authors, Reynolds RV first, J Am Acad Dermatol 2024 May;90(5):1006.e1-1006.e30, PMID 38300170, with a 2026 erratum on record. GRADE-based systematic review producing '18 evidence-based recommendations and 5 good practice statements'. Strong recommendations: benzoyl peroxide, topical retinoids, topical antibiotics, oral doxycycline, and oral isotretinoin for acne that is severe, causing psychosocial burden or scarring, or failing standard therapy. Conditional: topical clascoterone, salicylic acid, azelaic acid, oral minocycline, sarecycline, combined oral contraceptives, spironolactone. DENOMINATOR CORRECTION: the abstract names only FOUR of the five good practice statements — combining topical therapies with multiple mechanisms of action, limiting systemic antibiotic use, combining systemic antibiotics with topical therapies, and adding intralesional corticosteroid injections for larger acne lesions. Comedone extraction appears in none of the 18 recommendations or the four named good practice statements; the fifth good practice statement is not identified in the abstract and could not be checked. Scope limit and access failure: this is a US guideline with no UK legal or NHS standing, and the full text is paywalled (jaad.org returned HTTP 403 and no PMC deposit exists), so the widely-repeated secondary claim that the work group found 'insufficient evidence' to recommend comedo extraction could NOT be verified against the source and is not asserted here.Funding / interest: Guideline produced by the American Academy of Dermatology. Full COI statement retrieved and read in full. Reynolds, Cheng, Druby, Tollefson and Han declare no relationships. Barbieri declares NIH and National Psoriasis Foundation research funding only; Yeung, Freeman and Wu declare non-commercial or publisher roles. Cook-Bolden, Desai, Keri, Stein Gold, Tan, Weiss and Zaenglein declare extensive industry relationships (advisory boards, consultancies, speaker fees and research funding from AbbVie, Galderma, Ortho Dermatologics, Pfizer, Bausch, L'Oreal, Cutera, Incyte, UCB and many others). No author declares an interest in any comedone-extraction instrument, which is unsurprising given the procedure is not addressed.
  4. Yuan Y, Wang Y, Xia J, et al. Topical, light-based, and complementary interventions for acne: an overview of systematic reviews. Cochrane Database Syst Rev. 2024 Oct 23;10(10):CD014918. PMID 39440650, PMC11497561.Tier 1Supports: Full text fetched from PMC and independently searched by this verifier. Stated objective includes 'non-pharmacological interventions (physical therapy and complementary therapies)'. 733 records assessed; only six reviews (five Cochrane, one non-Cochrane) with low risk of bias met inclusion, covering 40,910 people with acne from 275 trials and 1,316 people with acne scars from 37 trials. Authors' conclusion: 'We found no high-certainty evidence for the effects of any therapy included.' Load-bearing negative, INDEPENDENTLY REPRODUCED: a full-text string search of the published review returns ZERO occurrences of 'comedo extraction' or 'comedone extraction'; all twelve hits for the word 'extraction' are 'data extraction' in the methods, COI and search-strategy sections. The largest recent evidence synthesis covering physical therapies for acne does not evaluate the procedure at all. Scope limit: searches ran to 2 December 2021, so the 2024 split-face RCT (source 5) postdates it and its absence is not evidence of appraisal and rejection.Funding / interest: All nine authors declare no conflict of interest. FIVE (not three) disclose an editorial role at Cochrane or authorship of an included review and recused themselves from assessing it: Jun Xia (editor, Cochrane Schizophrenia; author of Liu 2020), Haibo Liu (author, Liu 2020), Jian Ping Liu (editor, Cochrane Hepato-Biliary; author of Cao 2015), Huijuan Cao (author, Cao 2015) and Hong Sang (author, Liu 2020). No commercial funding declared.
  5. Yang MY, Qiao SM, Ning DC, Ding YH, Zeng WH, Wang Z. Treatment effect of ultra-pulse dynamic CO2 laser and comedone extractor in dense comedones: a prospective, randomized, split-face, evaluator-blind, controlled clinical trial. Lasers Med Sci. 2024 Sep 5;39(1):233. PMID 39235691.Tier 2Supports: Abstract fetched verbatim from PubMed; every number independently checked against it. Randomised trial in which manual comedone extraction is an allocated arm. Single-centre (Second Affiliated Hospital of Xi'an Jiaotong University), randomised, single-blind (evaluator-blind), split-face self-controlled design in patients with dense comedones; each side received either ultra-pulse dynamic CO2 laser or comedone extraction, four sessions at two-week intervals. Results: mean comedone reduction rate 46.36% on the extraction side vs 64.49% for CO2 laser (P<0.001). 79.16% of laser-treated sides reached over 50% reduction, vs 37.5% of extraction-treated sides — note the abstract attaches P<0.001 to the reduction-rate comparison only and reports no P value for the responder-rate comparison. Texture index, porphyrin index, red zone, erythema index and transepidermal water loss decreased after both treatments, with more improvement on the laser side; no difference in hydration index or melanin index. The abstract states the laser had lower pain scores, i.e. extraction was more painful. 'No permanent or severe side effects were observed on both sides.' The authors' own framing of the extractor, in the introduction: 'Comedone extractor has been widely employed by dermatologists, but the effect is temporary and may cause irritation.' Scope limits: exact sample size is not stated in the abstract or the publisher landing page and the full text is paywalled (the reported 79.16%/37.5% figures are arithmetically consistent with 24 participants, but this is inference and is not asserted); single Chinese centre; Fitzpatrick phototypes not reported; 'dense comedones' population, not general acne; no untreated control side, so neither arm is tested against doing nothing.Funding / interest: Not retrievable. PubMed carries no conflict-of-interest or funding statement for this record, and the Springer full text is behind an authentication redirect, so declarations could not be read. This matters because the trial's finding favours a laser device over the manual comparator and any device-manufacturer interest can be neither confirmed nor excluded.
  6. Bencharattanaphakhi R, Wananukul S, Tempark T, Chatproedprai S. A 595 nm pulsed dye laser as an adjuvant intervention for post-comedone extraction erythema and comedone reduction: A randomized, split-face controlled trial. J Cosmet Dermatol. 2024 May;23(5):1645-1653. PMID 38192163.Tier 2Supports: Randomised split-face trial in 35 participants aged 12.9-24.2 years with mild-to-moderate acne; three comedones were extracted on each facial side, with 595-nm pulsed dye laser applied to one side. Establishes post-comedone extraction erythema (PCEE) as a named, expected consequence of the procedure: the paper's stated premise is that 'Comedone extraction provides greater satisfaction for acne treatment than conventional treatment alone; however, post-comedone extraction erythema (PCEE) remains a concern for patients.' Erythema index on the PDL side was significantly lower at weeks 2 and 4 (p<0.001), and total acne lesion count was lower at week 2 (p<0.001) and week 4 (p=0.02). 'No complications were noted.' Scope limits: the trial randomises the LASER, not the extraction — both sides were extracted, so it provides no evidence that extraction works; paediatric dermatology setting in Thailand; Fitzpatrick phototypes not reported in the abstract; only three comedones per side; four-week follow-up, far too short to capture PIH or scarring.
  7. Lowney ED, Witkowski J, Simons HM, Zagula ZW. Value of comedo extraction in treatment of acne vulgaris. JAMA. 1964 Sep 28;189:1000-1002. PMID 14188876. (PubMed indexes the second author without an initial, as 'WITKOWSKI'.)Tier 3Supports: ACCESS CORRECTION: the JAMA full-article URL originally cited returns HTTP 403 behind a Cloudflare interstitial to automated fetchers; only the abstract page is readable, and that is what is quoted here. The definitive older primary source, and still the only located dedicated within-patient comparison of extraction against no extraction. Design, verbatim: 'Comedones and closed comedones were extracted unilaterally from the foreheads of 20 patients and from the cheeks of 12 patients with acne vulgaris.' DENOMINATOR CORRECTION: the abstract does not state whether the forehead and cheek groups were distinct patients, so a total of 32 is an inference and is not asserted. Findings, verbatim: the procedure 'was effective in most patients in preventing the development of inflamed acne lesions when applied to the forehead and when applied to other areas in patients with very superficial forms of acne'. Negative finding, reported by the authors: 'The procedure was rarely of value in cystic acne.' Scope limits: 1964; no randomisation, no blinding, no lesion counts, no statistical testing and no adverse-event reporting are described in the accessible record; skin phototypes not reported; the full text beyond the abstract is paywalled and Cloudflare-blocked.
  8. Tsukayama A, Yoshinaga A. Studying the efficacy of a new radical treatment for acne vulgaris using a surgical technique. J Dermatolog Treat. 2019 Dec;30(8):802-808. PMID 30706730.Tier 3Supports: Included because its headline number is widely quoted as proof that extraction cures acne, and it does not show that. Uncontrolled case series from a single private clinic in Kobe, Japan, of a NON-STANDARD technique: 'This surgical technique utilizes tweezers to widen the hair follicle to discharge comedo and pus completely and quickly from the acne.' Reported outcome: of 4,566 patients, approximately 85% were 'cured' within 1-10 treatments, 93% within 1-20, and 99% within 1-50. Scope limits that make the number uninterpretable: no control group, no randomisation, no blinding, no validated outcome measure or definition of 'cure', no baseline severity distribution, no follow-up duration, no adverse-event denominator, and no comparison against natural history or concurrent medical therapy. It is also not comedone extraction with a loop extractor — it is follicular widening with tweezers, and should not be cited as evidence for the standard procedure.Funding / interest: No funding or conflict-of-interest statement appears in the PubMed record. Both authors practise at the Yamate Clinic, Kobe — the single private clinic whose own newly-developed proprietary technique the paper reports and promotes. That is a direct commercial and reputational interest in the reported outcome, and it is undeclared.
  9. Abad-Casintahan F, Chow SK, Goh CL, et al; Asian Acne Board. Frequency and characteristics of acne-related post-inflammatory hyperpigmentation. J Dermatol. 2016 Jul;43(7):826-828. PMID 26813513.Tier 3Supports: Abstract fetched verbatim from PubMed and every figure checked. 324 sequential acne subjects evaluated across seven Asian countries by the Asian Acne Board; 80.2% had mild to moderate acne; 63.0% female, 37.0% male. 58.2% (188/324) had post-inflammatory hyperpigmentation. PIH was long-lasting: at least one year in more than half of subjects and five years or longer in 22.3%. Patients reported PIH as 'often as bothersome or more so than the acne itself'. Directly relevant to manipulation: 'Excoriation was commonly reported by patients, and may represent a modifiable risk factor that could potentially be improved by patient education.' SCOPE CORRECTION: Fitzpatrick III-VI appears only in the paper's framing sentence ('In patients with darker skin types (Fitzpatrick phototypes III-VI), acne is often accompanied by PIH'). The abstract does NOT report that phototype was measured or that all 324 subjects were III-VI, so the 58.2% figure must not be presented as a phototype-stratified result. Further scope limits: dermatology-clinic populations in Asia, so not representative of a UK aesthetic-clinic caseload; described by its own authors as a 'preliminary evaluation'; excoriation is self-inflicted picking, not professional extraction, and no dose-response or causal analysis was performed.Funding / interest: Funding and sponsorship are not stated in the accessible record. The Asian Acne Board is a standing international dermatologist group whose members declare industry relationships in other publications, but no disclosure statement is available for this paper, so a commercial interest can be neither confirmed nor excluded.
  10. Zhang J, Stringer MD. Ophthalmic and facial veins are not valveless. Clin Exp Ophthalmol. 2010 Jul;38(5):502-510. PMID 20491800.Ex vivoTier 3Supports: Cadaveric dissection study: 12 superior and 8 inferior ophthalmic veins plus 13 angular and facial veins harvested from adult cadavers, opened longitudinally and examined by stereomicroscopy. Ten valves were found in nine (75%) superior ophthalmic vein specimens; no valves in the inferior ophthalmic vein; 17 bicuspid valves in tributaries of the angular vein or in the facial vein, but none in the angular vein itself; 4 of 7 facial vein segments extending to the lower mandibular border had valves. Authors' conclusion, verbatim: 'It is not the absence of venous valves but the existence of communications between the facial vein and cavernous sinus and the direction of blood flow that is important in the spread of infection from the face.' Scope limits: human tissue outside the body (ex-vivo), small specimen numbers, single anatomy department, and it establishes anatomy only — it does not measure any clinical risk from any procedure.
  11. Khunger N; IADVL Task Force. Standard guidelines of care for acne surgery. Indian J Dermatol Venereol Leprol. 2008 Jan;74(Suppl):S28-36. PMID 18688101.Tier 4Supports: Full text fetched and read; every quotation below reproduced verbatim from it by this verifier. The most explicit published technique standard located for the procedure. POSITIVE FINDING, PREVIOUSLY OMITTED: this guideline RECOMMENDS comedone extraction. Under 'Recommendations A. Active Acne', it lists for 'Grade 1: Predominantly comedonal acne — Comedone extraction; Superficial chemical peels', and states 'The aim of treatment is a quicker resolution of lesions, thus reducing inflammation and minimizing scarring. However, some experts believe scarring may increase if not done with due precautions.' It nonetheless grades 'Comedone Extraction: (Level D)' — the lowest evidence grade in its own A-D scheme, against 'Superficial Chemical Peels: (Level B)' in the same document. Technique, verbatim: 'It is a process of applying simple mechanical pressure with a comedone extractor, to express the contents of the blocked pilosebaceous follicle.' / 'After cleansing with spirit, the comedone extractor is centred over the comedone and firm downward pressure is applied along the direction of the hair follicle to express the contents.' / 'For closed comedones, the top of the lesion is first pierced with a 21 G needle to make extrusion less traumatic.' / 'Undue force, which could increase inflammation and lead to potential scarring, should never be applied.' Positioning: 'Surgical treatment is only an adjunct to medical therapy, which remains the mainstay of treatment.' Scope of practice: 'Any Dermatologist can perform most acne surgery techniques as these are usually taught during postgraduation.' Facility: 'Most acne surgery procedures can be performed in a physician's minor procedure room.' Scope limits: 2008 Indian national association consensus, not UK; it assumes a medically qualified dermatologist operator; it specifies spirit cleansing but sets no instrument sterilisation or single-use standard; it carries no legal force in the UK.
  12. Kim RH, Armstrong AW. Current state of acne treatment: highlighting lasers, photodynamic therapy, and chemical peels. Dermatol Online J. 2011 Mar 15;17(3):2. PMID 21426868.Tier 4Supports: Narrative (non-systematic) review naming comedo extraction alongside light/laser therapy, photodynamic therapy and chemical peels as adjunctive in-office treatments 'growing in popularity'. Its own verdict on that class, verbatim: 'Whereas adjunctive therapies are generally well-tolerated, the number of randomized controlled trials are few and limited by small sample sizes.' Scope limits: narrative review with no stated search strategy, no risk-of-bias assessment and no quantitative synthesis — tier 4, not evidence of effect; US-authored; 2011, so predates both 2024 RCTs. Used here only to document that the thinness of the trial base has been openly acknowledged in the dermatology literature for over a decade.
  13. Department of Health and Social Care. The licensing of non-surgical cosmetic procedures in England: consultation document. Consultation open 2 September to 28 October 2023.Tier 1Supports: Fetched and read in full; green list reproduced verbatim by this verifier. This is the document that first assigns procedures to the proposed green/amber/red tiers, and it is a PROPOSAL, not law. The proposed green list, verbatim: 'microneedling; mesotherapy; intense pulsed light (IPL) and light emitting diode (LED) therapies; chemical peels that involve destruction only into viable epidermis (the outermost layer of the skin); no-needle fillers including pneumatic devices that use intense pressure to pass substances through the epidermis; micropigmentation (semi-permanent make up), including microblading and nanoblading; non-ablative laser hair removal; photo rejuvenation'. Amber includes medium-depth peels; red includes deep/phenol peels and the highest-risk injectables. CRITICAL QUALIFIER: each tier is introduced with 'We propose this includes, but is not limited to, the following procedures', and the document states 'the procedures listed are indicative of the types of procedures that will be included in the licensing scheme - they are not a final or complete list and may change'. Load-bearing negative, independently reproduced: the strings 'comedo', 'comedone extraction' and 'acne surgery' return ZERO hits in the document; the only two hits for 'extraction' are PRP blood extraction and follicular unit extraction. But because the lists are expressly non-exhaustive, absence is silence, not exclusion. The document also states: 'Face masks and other ‘spa’ products that are not designed to penetrate the outermost layer of the skin, the epidermis, are excluded from the scheme. No licensing requirements will apply in relation to their use.'
  14. Department of Health and Social Care. The licensing of non-surgical cosmetic procedures in England: consultation response. Published 7 August 2025.Tier 1Supports: Fetched and read. CORRECTION TO THE PREVIOUS READING OF THIS SOURCE: the response does NOT merely report on the tiers — it restates all three proposed tier lists verbatim ('The consultation proposed that the green/amber/red category includes, but is not limited to, the following procedures...') and then states: 'Based on the views expressed through the responses to this consultation, we are not proposing at this stage to remove any of the procedures currently included within the scope of the licensing scheme or associated regulation, nor are we proposing to add any further procedures.' So the 2023 tier placements stand unchanged at this stage; what the response does not do is finalise them in law. Response figures, checked: 11,533 responses on the green category, 69% agreeing ('Over two-thirds (69%) of respondents agreed with the categorisation of procedures in the green category'); amber attracted the least support at 51% (only 30% among aesthetic practitioners); red 71%. Next steps, verbatim in substance: government 'will therefore prioritise initial work in this space on the introduction of legislation which will ensure that those procedures deemed to pose the highest level of risk... can only be performed by suitably qualified regulated healthcare professionals working for CQC-registered providers', with 'The proposed changes will be detailed in a public consultation, to be launched early next year'; officials will 'continue the work instigated by the previous government to develop and implement local authority licensing for lower-risk procedures' under the Health and Care Act 2022. The phrase 'subject to secondary legislation' does not appear in the document and is not attributed to it. Comedone extraction returns zero hits here too. No licensing scheme is in force in England as at 2 August 2026.
  15. Medicines and Healthcare products Regulatory Agency. Regulating medical devices in the UK. GOV.UK guidance.Tier 1Supports: Fetched and read (page last updated 20 February 2026). Devices placed on the Great Britain market are regulated under the Medical Devices Regulations 2002 (SI 2002 No 618, as amended). The UKCA marking is 'a UK product marking used for certain goods, including medical devices, being placed on the Great Britain market (England, Wales and Scotland)'; Northern Ireland requires CE marking. IMPORTANT QUALIFIER, PREVIOUSLY MISSING: the guidance also states that 'the government has introduced measures which provide that CE-marked medical devices may be placed on the Great Britain market' to specified transitional timelines — so 'Great Britain requires UKCA' overstates the position; CE-marked devices remain lawfully placeable in GB during the transition. The MHRA 'performs market surveillance of medical devices on the UK market and is able to take decisions over the marketing and supply of devices in the UK', and registration with the MHRA is required before GB market placement. SCOPE LIMIT, LOAD-BEARING: this guidance sets the general framework only. It does not name comedone extractors or lancets, and it does not classify any specific instrument. Whether a given comedone extractor is a medical device turns on the manufacturer's stated intended purpose; many are marketed as beauty tools and are not placed on the market as medical devices at all. Any statement that comedone extractors ARE medical devices is an inference from this framework, not a finding in it. The guidance also sets no clinical technique, decontamination or single-use standard for any aesthetic procedure, and the MHRA's separate single-use-device reuse guidance could not be retrieved (GOV.UK returned 404 for the expected URLs and its search API did not surface it).
  16. Joint Council for Cosmetic Practitioners (JCCP). Public register of practitioners — treatment modalities.Tier 4Supports: Fetched. The JCCP public register is filterable by five treatment modalities and five only: chemical peels and skin rejuvenation; lasers, IPL and LED treatments; dermal fillers; botulinum toxins; hair restoration surgery. Comedone extraction is not a registrable modality and therefore has no JCCP/CPSA benchmark competence standard against which a practitioner's training can be measured. Scope limit: the JCCP is a voluntary self-regulatory body with no statutory powers; absence from its register is not a prohibition.
  17. Non-surgical Procedures and Functions of Medical Reviewers (Scotland) Act 2026 (2026 asp 13). Passed by the Scottish Parliament 17 March 2026; Royal Assent 12 May 2026.Tier 1Supports: Fetched from legislation.gov.uk and verified by this verifier. Introduction page, verbatim: 'The Bill for this Act of the Scottish Parliament was passed by the Parliament on 17th March 2026 and received Royal Assent on 12th May 2026.' Schedule 1 ('Specified non-surgical procedures') lists ablative laser treatment, chemical peel penetrating deeper than the epidermis, dermal microcoring, injectable procedure, intravenous procedure, licensed procedure carried out with a prescribed anaesthetic, and licensed procedure carried out on an intimate area. Every paragraph of Schedule 1 carries the note 'not in force at Royal Assent, see s. 24(2)'; commencement is being brought forward by S.S.I. 2026/206. Load-bearing negative: the strings 'comedo' and 'extraction' return zero hits in Schedule 1. Scope limit: Scotland only; the Act prohibits specified procedures for under-18s and outside specified premises rather than creating a competence standard.
  18. The Civic Government (Scotland) Act 1982 (Licensing of Non-surgical Procedures) Order 2026 (S.S.I. 2026/87), schedule 1.Tier 1Supports: Fetched and read. Schedule 1 'Specified non-surgical procedures' lists exactly eight: chemical peels not penetrating deeper than the epidermis (including fruit acid and glycolic peels); cryolipolysis; cryotherapy (or cryocautery); electrocautery (or advanced electrolysis); high intensity focused ultrasound; microneedling to a depth of less than 1.5 mm; non-ablative laser and light treatment; radio frequency treatments. Paragraph 9 defines 'skin lesions or blemishes' to include acne. Load-bearing negative: 'comedo' and 'extraction' return zero hits — comedone extraction is not a licensable procedure in Scotland even though cryotherapy and electrocautery for acne lesions are. Scope limit: Scotland only; premises-and-practitioner licensing under the 1982 Act, not a clinical standard.
  19. Public Health (Wales) Act 2017 (anaw 2), section 57 'What is a special procedure?'. In force 29 November 2024 by S.I. 2024/1248.Tier 1Supports: Fetched and read. Verbatim: 'Each of the following is a special procedure for the purposes of this Part— (a) acupuncture; (b) body piercing; (c) electrolysis; (d) tattooing.' Commencement: 'S. 57 in force at 29.11.2024 by S.I. 2024/1248, art. 2(b)'. Comedone extraction is not a special procedure in Wales. Scope limit: Wales only; the Welsh scheme is a mandatory licensing regime for those four procedures and says nothing about any other treatment.